A follow-up study of 113 patients with suspicious iris nevi who were referred to our clinic between 1973 and 1991 was carried out by: reviewing their clinical records, fluorescein angiography, obtaining recent data with cooperation of their own or the referring ophthalmologist and contacting patient
RB1 genetic testing as a clinical service: A follow-up study
β Scribed by Cohen, Jennifer G. ;Dryja, Thaddeus P. ;Davis, Katherine B. ;Diller, Lisa R. ;Li, Frederick P.
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 90 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0098-1532
- DOI
- 10.1002/mpo.1213
No coin nor oath required. For personal study only.
β¦ Synopsis
Background:
Genetic testing for inherited predisposition to diverse cancers has recently become available as a clinical service. we conducted a follow-up study of the initial series of us families who underwent rb1 genetic testing to evaluate long-term effects of the service.
Procedure:
We enrolled 52 of 71 eligible families who responded to a follow-up study questionnaire administered 3-10 years after receipt of their rb1 results. each family had one proband with unilateral, non-familial retinoblastoma, which is associated with a 12% pre-test probability of hereditary retinoblastoma. rb1 testing identified germline rb1 mutations in five patients, lowered the carrier probability to 2% in 21 patients, and did not substantially modify the carrier probability in the remaining 26.
Results:
Diverse medical specialists offered and arranged for rb1 testing, and their recommendation was the most influential factor in the decision to be tested. pre-test counseling was provided by ophthalmologists (30), oncologists (11), and geneticists and genetic counselors (11). most respondents, regardless of test result, were satisfied and perceived gains from their genetic testing. based on small numbers, families with reduced likelihood of hereditary retinoblastoma reported more positive outcomes. parents of rb1 carriers were more likely to seek medical services, worry, and decide against having more children.
Conclusions:
This study demonstrates the feasibility of follow-up studies of families who had genetic testing. results from our small series suggest that genetic information and counseling are important components of rb1 clinical genetic testing, and long-term adverse effects of testing are uncommon.
π SIMILAR VOLUMES
## Background: There is evidence that negative affect (na) and anxiety sensitivity (as) predict the development of anxiety disorders, particularly panic disorder (pd). the main purpose of this study was to examine whether na and as will also predict the clinical course of pd. ## Methods: Particip
Predictive genetic testing for cancer allows identification of those with the mutation (mutation positive) who should undergo cancer surveillance aiming at early detection of cancer and those without the mutation (mutation negative), whose unnecessary worry can be alleviated and who need not undergo
A genetic follow-up study has been performed of 64 infants who were diagnosed as having Pierre Robin complex over a 23-year period in South Australia. Patients and their families were contacted, family history was obtained, and physical examinations were performed with an aim to detect heterogeneity